Ascendis Pharma A/S (ASND) Cash Flow Statement
Ascendis Pharma A/S (ASND) generated $349.5M of operating cash flow over the twelve months to 2026-06-30, spent $14.4M on capital expenditure and had free cash flow of $335.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ASNDAscendis Pharma A/SFollow ASND — free
—
Price chart with a free account
- Market cap
- 15.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -95.1 | -138.8 | -175.9 | -271.5 | -417.6 | -495.7 | -467.4 | -306.2 | 53.9 | 349.5 | |
| Capital expenditure | 0.9 | 2.6 | 5.2 | 19.9 | 23.7 | 14.5 | 2.4 | 1.4 | 8.5 | -14.4 | |
| Free cash flow | -96.0 | -141.5 | -181.1 | -291.4 | -441.4 | -510.2 | -469.8 | -307.6 | 45.4 | 335.1 |
USD millions · SEC XBRL
Ascendis Pharma A/S — questions
- What is Ascendis Pharma A/S's operating cash flow?
- $349.5M over the twelve months to 2026-06-30.
- How much does Ascendis Pharma A/S spend on capital expenditure?
- $14.4M over the twelve months to 2026-06-30.
- What is Ascendis Pharma A/S's free cash flow?
- $335.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Ascendis Pharma A/S's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.